IL6 and gastroenteritis: In addition, the reduction of both IL-6 and TNF-α is a well-known PPAR-α receptor-dependent action, which counteracts nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB)-dependent inflammation, and which has been proposed to mediate NAEs-induced anti-inflammatory actions on intestinal inflammation [35,36].